Response to Fall 2011 Article: Clinical Molecular Testing: Subspecialty, Entry-level or Specialist Certification

Abstract

1. Walter Oliveira, BS, MLS(ASCP)CMSI 1. Chair, Board of Governors, ASCP Board of Certification 2. Patricia Tanabe, MPA, MLS(ASCP)CM 1. Executive Director, ASCP Board of Certification It is easy to see the explosion of molecular tests and methods now being employed to improve the diagnostic information provided by the laboratory to clinicians in order to benefit a patient. And, it is true that not all molecular laboratories are the same when it comes to test menu, instrumentation or methods. The ASCP Board of Certification is proud to sponsor the Molecular Biology certification exam because we believe certification matters in the laboratory and for the health of the patient. When due diligence was conducted with the former NCA staff for the two molecular exams that existed pre-merger, it was determined both exams were entry level and the use of the word “specialty” for the former NCA exam did not contain a different body of knowledge. NCA used the word specialty to convey a unique area of the laboratory, like hematology or cytogenetics, whereas the BOC uses it denote a more complex body of knowledge requiring either two or three years of work experience, academic degree and/or certification for that content area. (Please refer to our website: [www.ascp.org/BOC][1] for information on certification) For this reason the two exams were merged into one, entry level certification. The MB exam committee is comprised of content experts and practicing technologists, directors, educators and pathologists who collectively know the field as well as the need for competent and qualified staff. Because the current MB exam is meant to be an entry level certification, the eligibility routes are appropriate. We have an established… [1]: http://www.ascp.org/BOC